Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27314294)

  • 1. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
    Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.
    Wang Y; Wang M
    BMC Gastroenterol; 2016 Jul; 16(1):74. PubMed ID: 27457107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
    Guo C; Wang W; Shi Q; Chen P; Zhou C
    Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P; Lu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.